British Association for Psychopharmacology

To advance research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry, British Association for Psychopharmacology is formed in 1974 which is largest in Europe and second largest in the world. The BAP is a scholarly society and enrolled philanthropy. It advances examination and training in psychopharmacology and related regions, and unites individuals in the scholarly world, wellbeing administrations, and industry. The BAP is relevant to all therapists, neuroscientists, pharmacologists, neurologists, drug specialists, and clinicians. Its participation and interests cover every single significant system utilized as a part of the field, including: pharmacology, hereditary qualities, neuroimaging, neuropsychology, electrophysiology, trial drug, clinical trials, and in vivo and in vitro models. The BAP uses two interlinked areas- The biological basis of brain and behaviour, and its alterations in psychiatric disorders and study of drugs used to treat disorders of brain and behaviour-the targets, mechanisms of action, effectiveness, and side-effects of current & novel treatments, and drugs of abuse. This society values the contribution from both its clinical and other researchers. There is a balance between these groups in terms of the scientific content of all meetings, and representation on BAP Council.

The following is the list of scholars from British Association for Psychopharmacology who contributed and/or serves as editors for one or more OMICS International journals and conferences

• Ahmed Naguy